Myeloid sarcoma of the posterior mediastinum mimicking lymphoma: Potential role of dual-energy CT Authors: Xiaobo Tang, Tingting Zhao, Zhoupeng Ma, Jiwen Kang, Ya Chen, Xifu Wang Published: 2026 ABSTRACT Myeloid sarcoma is a rare extramedullary malignant tumor composed of immature myeloid cells and is frequently associated with acute myeloid leukemia. Isolated mediastinal involvement is exceedingly uncommon and often poses a significant diagnostic challenge because of nonspecific clinical and imaging features, frequently leading to misdiagnosis as lymphoma. We report posterior mediastinal myeloid sarcoma in a 39-year-old man who presented with back pain and chest discomfort. Conventional contrast-enhanced computed tomography demonstrated a homogeneous posterior mediastinal soft-tissue mass encasing the descending aorta, and lymphoma was initially suspected. Contrast-enhanced dual-energy computed tomography demonstrated low iodine uptake and a relatively flat spectral attenuation curve, providing supplementary information for lesion characterization and imaging-pathology correlation. The final diagnosis was established after surgical resection by histopathological and immunohistochemical examination. This case suggests that dual-energy computed tomography may be a useful adjunctive imaging tool in selected mediastinal tumors; however, its findings should be interpreted cautiously and cannot replace histopathological, immunohistochemical, and hematological evaluation. Introduction Myeloid sarcoma (MS), also known as granulocytic sarcoma or chloroma, is a rare extramedullary tumor composed of immature myeloid precursor cells. It may occur de novo, precede acute myeloid leukemia (AML), coexist with AML, or represent relapse of a myeloid neoplasm [1,2]. MS can arise in virtually any organ, including the skin, bone, soft tissue, lymph nodes, gastrointestinal tract, and central nervous system, and its clinical presentation is often nonspecific [1,3]. Mediastinal involvement, particularly in the posterior mediastinum, is uncommon and may mimic lymphoma, neurogenic tumors, metastatic disease, or other soft-tissue tumors [4,5]. Computed tomography (CT) is commonly used as the first-line imaging modality for evaluating mediastinal masses because it can demonstrate lesion location, morphology, enhancement pattern, and relationship to adjacent structures [6]. However, conventional CT findings of MS may overlap with those of lymphoma and other mediastinal tumors. Dual-energy CT (DECT) can generate iodine maps, virtual monochromatic images, and effective atomic number maps, providing quantitative information beyond conventional attenuation values [7]. We report a case of posterior mediastinal MS initially suspected to be lymphoma, with a focus on the supplementary role and limitations of DECT. Case report A 39-year-old man with no significant past medical history presented with a 2-week history of persistent dull back pain accompanied by intermittent chest discomfort. He denied fever, night sweats, weight loss, dyspnea, dysphagia, or neurological symptoms. There was no history of hematological disease, including leukemia or myelodysplastic syndrome. Laboratory tests revealed a white blood cell count of 3.90 × 109/L, hemoglobin of 145 g/L, and platelet count of 347 × 109/L. C-reactive protein was mildly elevated. Lactate dehydrogenase was increased, while tumor markers were largely within normal limits. Because lymphoma was initially suspected clinically, a comprehensive hematological workup, including bone marrow biopsy and peripheral smear evaluation, was not performed before surgery. The patient underwent contrast-enhanced chest dual-energy CT using a uCT 960+ dual-energy CT scanner (United Imaging Healthcare, Shanghai, China). The patient was placed in the supine position with both arms raised. The scan range extended from the thoracic inlet to the inferior margin of the bilateral costophrenic angles, and scanning was performed during end-inspiratory breath-holding. Dual-energy acquisition was performed with tube voltages of 80/140 kVp, automatic tube current modulation, a collimation width of 40 mm, a pitch of 0.9625, a gantry rotation time of 0.5 s/rotation, and a scan time of approximately 4.5 seconds. For contrast-enhanced scanning, a nonionic iodinated contrast medium, iohexol injection (Beijing Beilu Pharmaceutical Co., Ltd., Beijing, China; 35 g iodine [I] per 100 mL), was administered at a dose of 1.3 mL/kg, with a total volume of 90 mL, via high-pressure injection through an antecubital vein, followed by a saline flush. The raw dual-energy data were transferred to a uWS-CT image postprocessing workstation (United Imaging Healthcare, Shanghai, China). Virtual monochromatic images, iodine-based images, and effective atomic number maps were reconstructed, and spectral parameters of the lesion were measured. Regions of interest (ROIs) were manually placed in the solid portion of the lesion and in the thoracic aorta on the same slice, while avoiding necrotic, calcified, cystic, and vascular areas. Measurements were repeated 3 times, and the mean values were used for analysis. Iodine concentration (IC), normalized iodine concentration (NIC), effective atomic number (Zeff), normalized Zeff, virtual monochromatic CT attenuation values, and the spectral attenuation curve slope were recorded. The spectral attenuation curve slope was calculated as follows: λHU = (CT40 keV − CT140 keV)/100 [8]. Noncontrast and contrast-enhanced chest CT revealed a homogeneous soft-tissue mass in the posterior mediastinum at the T7-T11 levels, showing mild homogeneous enhancement (Fig. 1A and B). The mass extended bilaterally along the paravertebral region and encased the descending aorta without evidence of vascular invasion (Fig. 1C). These nonspecific findings overlapped substantially with the typical CT appearance of mediastinal lymphoma [6].Fig. 1(A) Noncontrast chest CT shows a homogeneous soft-tissue mass in the posterior mediastinum encasing the descending aorta (arrow). (B) Contrast-enhanced venous-phase CT demonstrates mild homogeneous enhancement of the lesion with well-defined margins (arrow). (C) Coronal reconstructed image reveals bilateral paravertebral extension of the lesion along the spine (long arrow) and its close relationship with the descending aorta (short arrow).Fig 1 dummy alt text (A) Noncontrast chest CT shows a homogeneous soft-tissue mass in the posterior mediastinum encasing the descending aorta (arrow). (B) Contrast-enhanced venous-phase CT demonstrates mild homogeneous enhancement of the lesion with well-defined margins (arrow). (C) Coronal reconstructed image reveals bilateral paravertebral extension of the lesion along the spine (long arrow) and its close relationship with the descending aorta (short arrow). DECT iodine maps demonstrated low iodine uptake within the lesion, with an IC of 5.7 × 102 µg/cm3, compared with an aortic IC of 45.5 × 102 µg/cm3 (Fig. 2). The NIC, calculated as lesion IC divided by aortic IC, was 0.125. On virtual monochromatic images, the lesion showed attenuation values of 78.5 HU at 40 keV and 51.5 HU at 140 keV, whereas the corresponding aortic attenuation values were 412.5 HU and 58.5 HU. The lesion showed a relatively flat spectral attenuation curve with a slope of 0.27 (Fig. 3A and B). These DECT findings provided supplementary information but were not considered diagnostic.Fig. 2The dual-energy computed tomography iodine map shows low iodine uptake within the lesion. The long arrow indicates the region of interest (ROI) within the lesion, and the short arrow indicates the ROI within the thoracic aorta. The iodine concentration within the lesion is 5.7 × 102 µg/cm3, and the iodine concentration within the aorta is 45.5 × 102 µg/cm3.Fig 2 – dummy alt textFig. 3(A) Regions of interest were placed within the lesion (ROI 1, long arrow) and in the thoracic aorta at the same level (ROI 2, short arrow). (B) Spectral attenuation curve of the lesion (ROI 1) shows a spectral attenuation curve slope (λHU) of 0.27. At X-ray photon energies of 40 keV and 140 keV, the attenuation values of the lesion were 78.5 HU and 51.5 HU, respectively, while the corresponding attenuation values of the aorta (ROI 2) were 412.5 HU and 58.5 HU.Fig 3 – dummy alt text The dual-energy computed tomography iodine map shows low iodine uptake within the lesion. The long arrow indicates the region of interest (ROI) within the lesion, and the short arrow indicates the ROI within the thoracic aorta. The iodine concentration within the lesion is 5.7 × 102 µg/cm3, and the iodine concentration within the aorta is 45.5 × 102 µg/cm3. (A) Regions of interest were placed within the lesion (ROI 1, long arrow) and in the thoracic aorta at the same level (ROI 2, short arrow). (B) Spectral attenuation curve of the lesion (ROI 1) shows a spectral attenuation curve slope (λHU) of 0.27. At X-ray photon energies of 40 keV and 140 keV, the attenuation values of the lesion were 78.5 HU and 51.5 HU, respectively, while the corresponding attenuation values of the aorta (ROI 2) were 412.5 HU and 58.5 HU. The patient underwent surgical resection. Microscopic examination revealed that the tumor was composed of mononuclear cells with oval to irregular nuclei arranged in diffuse sheets, with frequent mitotic figures (Fig. 4A and B). Immunohistochemical analysis (IHC No. 25-00911) showed that the tumor cells were positive for CD34, CD99, and CD117, and weakly positive for LCA, MPO, CD2, vimentin, and cytokeratin (focal weak staining), while TdT was only focally positive. The tumor cells were negative for CD3, CD5, CD7, CD4, CD8, CD15, CD20, CD19, CD30, PAX5, CD163, SALL4, INSM1, PAX8, and p63 (Fig. 4C). Based on the histopathological and immunohistochemical findings, the final pathological diagnosis was MS.Fig. 4(A and B) Hematoxylin and eosin–stained sections at × 100 (A) and × 200 (B) magnification show diffuse sheets of mononuclear tumor cells with oval to irregular nuclei and frequent mitotic figures. (C) Immunohistochemical staining demonstrates positivity for CD34.Fig 4 – dummy alt text (A and B) Hematoxylin and eosin–stained sections at × 100 (A) and × 200 (B) magnification show diffuse sheets of mononuclear tumor cells with oval to irregular nuclei and frequent mitotic figures. (C) Immunohistochemical staining demonstrates positivity for CD34. Discussion MS is a rare extramedullary tumor that may occur de novo, precede AML, coexist with AML, or represent relapse of a myeloid neoplasm [1,2]. Because MS can involve almost any anatomic site and often lacks specific clinical manifestations, its diagnosis is challenging, particularly in patients without a known history of hematological malignancy [1,3]. Mediastinal MS is particularly uncommon and may mimic lymphoma, neurogenic tumors, metastatic disease, or other soft-tissue sarcomas [4,5]. In the present case, the lesion was located in the posterior mediastinum and appeared as a relatively homogeneous soft-tissue mass encasing the descending aorta. These imaging findings were nonspecific and overlapped with those of lymphoma and other posterior mediastinal tumors. Therefore, lymphoma was initially suspected clinically, and the patient underwent surgical resection without a preoperative diagnosis of MS. The final diagnosis was established by postoperative histopathology and immunohistochemistry, highlighting the essential role of pathological confirmation in mediastinal MS [1,4,5]. Conventional contrast-enhanced CT is useful for evaluating the location, morphology, enhancement pattern, and relationship of a mediastinal mass to adjacent structures [6]. However, conventional CT findings alone are usually insufficient to distinguish MS from lymphoma or other mediastinal malignancies. In this case, contrast-enhanced DECT provided additional quantitative information by generating iodine maps, virtual monochromatic images, and effective atomic number maps [7,9]. The low iodine uptake and relatively flat spectral attenuation curve may reflect limited vascularity and homogeneous soft-tissue composition of the lesion. These findings may help refine lesion characterization and support imaging-pathology correlation. However, the diagnostic role of DECT should not be overstated. The present report describes only a single case, and DECT findings cannot be regarded as specific for MS. DECT-derived parameters, including iodine concentration, effective atomic number, virtual monochromatic attenuation, and spectral attenuation curve slope, may be influenced by scanner type, acquisition protocol, contrast injection protocol, scan timing, postprocessing software, ROI placement, and tumor heterogeneity [7,9]. Therefore, DECT should be considered a complementary imaging tool rather than a definitive diagnostic method. Histopathology and immunohistochemistry remain essential for diagnosis [1]. Other imaging modalities may provide additional information in selected cases. MRI may be helpful for assessing soft-tissue extension, spinal canal involvement, or bone marrow infiltration, whereas PET/CT may assist in whole-body staging and detection of multifocal extramedullary disease [10]. However, neither modality can replace tissue diagnosis, and their use should be determined according to clinical suspicion and staging requirements. Therapeutic options include systemic chemotherapy, radiotherapy, hematopoietic stem cell transplantation, targeted therapy, immunotherapy, and surgical intervention [2]. A limitation of this report is that a comprehensive hematological workup was not performed before surgery because lymphoma was initially suspected clinically. Therefore, although the diagnosis of MS was confirmed by postoperative histopathology and immunohistochemistry, the possibility of occult systemic hematological involvement could not be fully assessed at the preoperative stage. This limitation further emphasizes that imaging findings, including DECT features, should be interpreted together with histopathological, immunohistochemical, and hematological evaluation [1]. In conclusion, posterior mediastinal MS is extremely rare and may closely mimic lymphoma or other mediastinal tumors on conventional imaging. Contrast-enhanced DECT may provide supplementary quantitative information for lesion characterization and imaging-pathology correlation. However, DECT findings in a single case should be interpreted cautiously and should not be regarded as diagnostic. Histopathology and immunohistochemistry remain essential for definitive diagnosis, and comprehensive hematological evaluation is necessary to assess possible systemic involvement. Ethics statement This study was approved by the Ethics Committee of Shanghai General Hospital, Jiading Branch. Written informed consent was obtained from the patient for publication of this case report and accompanying images. Patient consent A written informed consent was obtained from the patient for the publication of this case report.